Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease

Simple item page
dc.contributor.authorWallentin, Lars
dc.contributor.authorHeld, Claes
dc.contributor.authorArmstrong, Paul W.
dc.contributor.authorCannon, Christopher P.
dc.contributor.authorDavies, Richard Y.
dc.contributor.authorGranger, Christopher B.
dc.contributor.authorHagstrom, Emil
dc.contributor.authorHarrington, Robert A.
dc.contributor.authorCorbalán Herreros, Ramón
dc.date.accessioned2021-05-13T17:49:51Z
dc.date.available2021-05-13T17:49:51Z
dc.date.issued2016
dc.format.extent16 páginas
dc.fuente.origenConveris
dc.identifier.doi10.1161/JAHA.116.003407
dc.identifier.issn2047-9980
dc.identifier.urihttps://doi.org/10.1161/JAHA.116.003407
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/58054
dc.issue.numeroNo. 6
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final16
dc.pagina.inicio1
dc.revistaJournal of the American Heart Associationes_ES
dc.rightsacceso abierto
dc.titleLipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart diseasees_ES
dc.typeartículo
dc.volumenVol. 5
sipa.codpersvinculados98700
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease.pdf
Size:
1.75 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas